导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.06% | 909/1053 |
| 近一周 | 1.26% | 752/1079 |
| 近一月 | -3.98% | 688/1081 |
| 近一季 | -10.28% | 860/1077 |
| 近半年 | -11.16% | 858/1047 |
| 近一年 | -4.49% | 809/995 |
| 近两年 | 10.74% | 711/913 |
| 近三年 | 7.34% | 561/812 |
| 成立以来 | 74.24% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.74% 941/1070 |
- - |
- - |
- - |
| 2025 | 6.37% 866/1065 |
-2.92% 951/1014 |
-0.66% 738/1038 |
8.53% 869/1050 |
1.62% 337/1065 |
| 2024 | 27.20% 36/1011 |
5.95% 87/960 |
-3.50% 549/983 |
21.13% 50/991 |
2.72% 212/1011 |
| 2023 | -10.78% 358/952 |
2.23% 496/880 |
-5.54% 561/895 |
-0.57% 103/915 |
-7.07% 682/952 |
| 2022 | -32.08% 664/867 |
-24.61% 712/773 |
7.60% 369/806 |
-9.66% 225/845 |
-7.32% 716/867 |
| 2021 | -7.19% 453/740 |
-4.08% 309/580 |
10.16% 353/659 |
-12.16% 563/704 |
- 438/740 |
| 2020 | 66.50% 157/554 |
1.56% 122/419 |
23.22% 223/466 |
12.96% 180/517 |
17.79% 158/554 |
| 2019 | 53.31% 126/410 |
26.17% 622/1146 |
-1.64% 495/1228 |
10.06% 107/390 |
12.24% 105/410 |
| 2018 | -30.54% 225/349 |
- - |
-9.48% 460/990 |
-8.58% 679/1000 |
-13.52% 792/1080 |
| 2017 | 30.13% 42/285 |
- - |
- - |
- - |
- - |
| 2016 | -4.68% 42/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国泰央企改革股票A VS. 东吴新产业精选股票A(580008) |